Vascular Access Technologies, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
3
Ending by 2030
Dec 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 23, 2026The maintenance fee for Devices for transvascular retrograde access placement (US 11,654,266) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
- 1 fee due Jan 9, 2027The maintenance fee for Transvascular access methods (US 10,342,956) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
- 1 fee due Jun 29, 2027The maintenance fee for Transvascular access device and method (US 9,220,874) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 1 fee due Oct 14, 2027The maintenance fee for Trans-jugular carotid artery access methods (US 10,617,854) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,654,266 | Devices for transvascular retrograde access placement In force · From the USPTO record | In force | From the USPTO record | |
| US 8,568,435 | Transvascular retrograde access devices In force · From the USPTO record | In force | From the USPTO record | |
| US 8,409,236 | Methods of transvascular retrograde access placement and devices for facilitating the placement In force · From the USPTO record | In force | From the USPTO record | |
| US 9,220,874 | Transvascular access device and method In force · From the USPTO record | In force | From the USPTO record | |
| US 10,252,027 | Transvascular Access Device and Method In force · Medium confidence | In force | Medium confidence | |
| US 10,342,956 | Transvascular access methods In force · From the USPTO record | In force | From the USPTO record | |
| US 11,376,403 | Transvascular access methods In force · From the USPTO record | In force | From the USPTO record | |
| US 9,511,214 | Methods of transvascular retrograde access placement and devices for facilitating therein In force · From the USPTO record | In force | From the USPTO record | |
| US 9,623,217 | Transvascular access methods In force · From the USPTO record | In force | From the USPTO record | |
| US 12,053,602 | Methods and devices for vascular access In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 15: 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 no status recorded